FINHUB Insights

CME · Q3 FY25 · Jul 1 – Sep 30, 2025

CME Q3 FY25: where the revenue came from and where it went

CME Q3 FY25: revenue $1.5B (−3% year over year). Net profit $0.9B. Largest cohort Clearing and transactionfees $1.2B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 24, 2025 10-Q
Sankey diagram of CME's income statement for Q3 FY25: revenue of $1.5 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$1.5B −3% year over year
Operating profit$1B 63% margin
Net profit$0.9B 59% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY25 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 1.5 100% −3%
Clearing and transactionfees 1.2 80% −5%
Market Data 0.2 13% +14%
Other Revenue 0.1 7% −2%
Operating expenses−0.637%+0pp
Operating profit163% margin−1pp
Tax−0.3
Net profit0.959%+1pp

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters